The perivascular adipose tissue (PVAT) surrounding vessels constitutes a distinct functional integral layer of the vasculature required to preserve vascular tone under physiological conditions. However, there is little information on the relationship between PVAT and blood pressure regulation, including its potential contributions to circadian blood pressure variation.
H
ypertension, a disorder of complex pathophysiology, is a major contributor to cardiovascular and renal diseases. Although the exact intricacies of hypertension pathogenesis remain unsolved, it is clear that this is a multifactorial, complex polygenic disorder with many interacting mechanisms contributing to its pathophysiology and involving many organ systems, including the heart, kidney, brain, vessels, and immune system. 1 Perivascular adipose tissue (PVAT) is de facto a distinct functional vascular layer and plays an active role in the control of vascular (dys)function in (patho)physiological conditions such as hypertension. 2, 3 Current studies show paradoxical effects of PVAT in the regulation of vascular tone. 2 On one hand, PVAT exerts anticontractile effects in various vascular beds, a phenomenon that seems to be mediated by some, still elusive, PVATderived relaxing factors (PVRFs). This anticontractile effect of PVAT is impaired in disease conditions such as metabolic syndrome 4, 5 and hypertension, [5] [6] [7] [8] further underscoring the physiological role of PVAT in vascular tone. PVRFs might include adiponectin, 9 ,10 H 2 S, 11 nitric oxide, 12 angiotensin (Ang)-(1-7), 13 palmitic acid methyl ester, 14 and prostacyclin. 15 On the other hand, we previously demonstrated that PVAT dramatically constricted carotid artery rings 15 and coronary artery PVAT of obese swine augmented vasoconstriction. 16 In addition, PVAT enhanced the mesenteric artery contractile response to perivascular nerve stimulation through the production of superoxide mediated by nicotinamide adenine dinucleotide (NADPH) oxidase. 17 Chemerin is expressed in PVAT and induces vasoconstriction. 18 Thus, apart from the existence of anticontractile PVRF in PVAT, the existence of PVAT-derived contractile factors must also be highlighted. A delicate balance between those 2 faces of PVAT on the regulation of vascular tone could contribute to the maintenance of vessel homeostasis and blood pressure (BP) regulation. Currently, direct evidence derived from animal models to support the notion of an anticontractile or contractile role for PVAT on the regulation of BP is largely missing. We reported that a mouse model lacking PVAT as a result of peroxisome proliferator-activated receptor-γ (PPARγ) deletion in vascular smooth muscle cells (VSMCs) presents hypotension in the resting period. However, it is not clear whether loss of PVAT or PPARγ deletion in VSMCs in these mice causes the hypotension. 19 Circadian variations in BP are among the best recognized circadian rhythms of physiology in humans 20 and rodents. 21 In humans, the highest BP is observed during the morning hours and the lowest during the sleep hours. This diurnal-nocturnal cycle of BP in rodents is reversed as the result of their nocturnal active phase. It is known that circadian rhythms in BP are controlled by the "master clock" located in the suprachiasmatic nucleus (SCN). 22 The positive (Clock, Npas2, and Bmal1) and negative (Per1, Per2, Per3, Cry1, and Cry2) arms of the clock genes in the SCN make up a negative feedback loop, resulting in cyclic activation of the transcriptional machinery of clock genes in an ≈24-hour cycle of biological rhythm. 23 Studies from animals and humans suggest that Bmal1 is associated with hypertension. The Bmal1 gene is located within hypertension susceptibility loci in rat and maps close to a region genetically divergent between spontaneously hypertensive rats and their normotensive counterparts. 24 Genetic association studies showed that 2 BMAL1 haplotypes were associated with hypertension 24 and that the rs3816358 single nucleotide polymorphism in BMAL1 was significantly associated with the nondipper phenotype in young hypertensive patients, suggesting a genetic association with diurnal BP changes in essential hypertension. 25 Indeed, disruption of master clock genes has been shown to change BP and alter circadian rhythms of BP. Con-
Clinical Perspective
What Is New?
• This is the first demonstration of a peripheral clock in perivascular adipose tissue (PVAT) contributing to the homeostatic regulation of circadian blood pressure variation.
• This study uses novel brown adipocyte-specific aryl hydrocarbon receptor nuclear translocator-like protein 1 (Bmal1)-and angiotensinogen-knockout mouse models to demonstrate that the PVAT peripheral clock safeguards optimal vascular tone during the resting phase.
• This study uncovered local angiotensinogen and angiotensin-converting enzyme circadian expression in PVAT and Bmal1-dependent transcriptional circadian regulation of angiotensinogen, which controls local levels of angiotensin II during the resting phase.
• This study found that deletion of Bmal1 or angiotensinogen in PVAT results in a superdipper phenotype (exacerbated hypotension) during the resting phase.
What Are the Clinical Implications?
• Alterations in the peripheral clock in PVAT regulating blood pressure could contribute to the adverse clinical cardiovascular outcomes observed in shift workers or in individuals with jet lag.
• It is possible that obesity could alter the PVAT peripheral clock to promote abnormal dipper phenotypes, increasing cardiovascular risk.
• These findings are likely relevant to the personalized design of clinical studies, including diagnosis, biopsy collection, and chronopharmacology. • The present results can inform the design of novel therapeutic approaches for hypertension by targeting the PVAT peripheral clock. 26 Mice with a mutation of Npas2 are hypotensive. 27 Clock-mutant mice exhibit only a subtle dampening of BP on light-dark conditioning. 27 Notably, mice with global deletion of Bmal1 showed evidence of abolished circadian rhythms of BP and were hypotensive. 27 However, the SCN master clock is not solely responsible for the circadian regulation of BP. Indeed, the components of the circadian clock genes are found in peripheral tissues, including blood vessels. 28 Furthermore, the peripheral circadian clocks can be uncoupled from the central SCN circadian clocks. 29 A robust diurnal variation in BP and lower BP during the dark phase were apparent in mice with endothelial cell (EC)-specific deletion of Bmal1. 30 PPARγ deletion in aortas repressed Bmal1 activity and herein disrupted circadian rhythms of BP. 31 In addition, selective deletion of Bmal1 in VSMCs decreased BP without affecting SCN-controlled locomotor activity in mice. 32 Together, these studies suggest that peripheral circadian clocks contribute to BP circadian rhythmicity.
The components of the renin-angiotensin system (RAS), including angiotensinogen (Agt) but not renin, are present in PVAT. 33 In fact, pretreatment of intact vessel rings with the selective Ang II antagonist SariIle8-Ang II significantly attenuated electric stimulationelicited contraction in a PVAT-dependent fashion. 34 Long-term treatment with an angiotensin-converting enzyme inhibitor, quinapril, alleviated the potentiation effects of PVAT in contraction upon electric stimulation, 35 further supporting a role for PVAT-derived Ang II in vasoactivity.
In this study, we report a peripheral circadian clock operating in PVAT-dependent circadian regulation of BP. Deletion of Bmal1 or Agt in brown adipocytes including PVAT dramatically reduced BP in the resting phase, resulting in a superdipper phenotype. Furthermore, we found that Bmal1 positively regulates Agt expression at the transcriptional level in PVAT adipocytes. Thus, Bmal1, Agt, and Ang II in PVAT coordinately contribute to the regulation of homeostatic circadian rhythmicity of BP during the resting phase.
METHODS
Detailed experimental methods are given in the online-only Data Supplement, and the list of primers is given in Table I in the online-only Data Supplement. Requests to access the data, analytical methods, and study materials for reproducibility purposes should be addressed to the corresponding authors.
Mice
Brown adipocyte-specific deletion of Bmal1 (BA-Bmal1-KO) or Agt (BA-Agt-KO) mice were generated by cross-breeding Bmal1 flox/flox (Jackson Laboratory, stock 007668) or Agt flox/flox mice (Jackson Laboratory, stock 018388) with UCP-1-driven Cre mice, 36 respectively (all in theC57BL/6 background). Eightweek-old male mice were used in this study, and age-matched wild-type littermate mice were used as controls. Mice were housed at the University of Michigan animal facility (≈22°C and 12/12-hour light/dark cycle) and supplied with rodent diet No. 2918 (18% protein, 6% fat, and moderate phytoestrogen; Harlan Laboratories) ad libitum. The Animal Research Ethics Committee of the University of Michigan approved the study protocol for animals. Telemetry, Ang II infusion, and aortic ring constriction in response to PVAT extracts were described previously 19, 37 and are further detailed in the onlineonly Data Supplement.
Statistical Analysis
Mean±SD values were determined with GraphPad Prism Software (version 7). Statistical comparisons between 2 groups were performed by Student's t test ( Figures 1C, 2C , 3A, 3D, 4C, and 5B through 5D) and >2 groups were performed by 1-way ANOVA ( Figures 1E, 2B , 2E, 3F, and 4F). Groups were considered significantly different at P<0.05.
RESULTS

Bmal1 Deficiency in Brown Adipocytes Reduces BP During the Resting Phase
Expression of Bmal1 and Clock mRNA in brown PVAT shows circadian rhythmicity ( Figure 1A ), higher at 6 am (the onset of resting phase), gradually reduced during the lights-on time (resting phase) to their lowest level at 6 pm, and progressively restored during the lights-off time (active phase) to their higher level at 6 am. Per1 and Rev-erbα mRNA show the opposite pattern. Furthermore, at pressor levels (500 ng·kg −1 ·min −1 ), Ang II infusion results in acute and sustained high levels of systolic BP (SBP), albeit with loss of circadian regulation for the first 3 days followed by a progressive restoration of the dipping ability during the resting phase by day 4 ( Figure IA in the online-only Data Supplement). Remarkably, the acute loss of circadian dipping in SBP is associated with reduced levels of Bmal1 protein in PVAT when the tissue was collected early in the resting phase ( Figure IB in the online-only Data Supplement). Subsequent recovery of circadian SBP variation was associated with a progressive restoration of Bmal1 protein levels in PVAT after day 4 of Ang II infusion. These data suggest that the peripheral clock in PVAT might contribute to physiological circadian regulation of BP with Bmal1 expression in PVAT positively associated with the dip in BP during the resting phase. This led to our hypothesis that Bmal1 and its target genes within PVAT may communicate timing information within the vessel beds to regulate BP.
Because adipocytes in mouse PVAT are brown adipocytes, 15, 38 we generated BA-Bmal1-KO mice to further understand the role of the PVAT peripheral clock on
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circadian regulation of BP. Bmal1 protein was detected in all types of adipose tissues and in the whole aorta in the wild-type mice, whereas Bmal1 was successfully deleted in PVAT and interscapular brown adipose tissue (BAT) of the BA-Bmal1-KO mice ( Figure 1B ). During the daytime resting phase, Bmal1 mRNA levels and its target circadian-related genes such as Dbp, Per3, and Reverbα were reduced, whereas Cry1, E4bp4, and Npas2 were increased in PVAT from BA-Bmal1-KO mice (Figure 1C ). As expected, loss of the regulatory circadian feedback loop was observed in the BAT also but not in other organs in BA-Bmal1-KO mice ( Figure II in the online-only Data Supplement). To determine the effects of loss of Bmal1 in brown adipocytes on BP rhythmicity, we used telemetry to measure the BP in mice kept in a 12/12-hour dark/light cycle. Unlike the global Bmal1 mice in which circadian rhythms of BP are abolished and the mice are hypotensive, 27 in a 22°C room temperature environment, BA-Bmal1-KO mice are hypotensive only during the resting phase (6 am-6 pm) and on average normotensive during the active period (6 pm-6 am; Figure 1D and 1E). Bmal1 depletion in brown adipocytes results in a ≈10% further reduction of BP during the resting phase (SBP, 116.8±7.7 mm Hg in wild-type mice and 104.4±4.5 mm Hg in BA-Bmal1-KO mice) with comparable BP during the active phase (SBP, 132.6±13.3 mm Hg in wild-type mice and 131.4±13.5 mm Hg in BA-Bmal1-KO mice), thus indicating that the BA-Bmal1-KO mice present an exacerbated hypotensive (superdipper) phenotype at rest. 39 The heart rates of the BA-Bmal1-KO mice were reduced during both the resting and active phases without affecting the locomotor activity ( Figure 1D and 1E). However, the cardiac function parameters during the resting phase were comparable between wild-type and BA-Bmal1-KO mice ( Figure IC in the online-only Data Supplement).
Because heart rate can be a determinant of diurnal changes in arterial pressure in mice, 40 we injected 10 mg/ kg isoproterenol IP to increase the heart rate of BA-Bmal1-KO mice to match that of the wild-type mice ( Figure Circulation. ORIGINAL RESEARCH ARTICLE was restored about 1 hour after injection of isoproterenol during the resting phase. However, recovery of BP in the BA-Bmal1-KO mice significantly lagged. When injection of isoproterenol was performed in the evening (active phase), recovery of SBP of BA-Bmal1-KO mice slightly lagged, with comparable diastolic BP levels between wildtype mice and BA-Bmal1-KO mice despite the same levels of heart rates in both wild-type and BA-Bmal1-KO mice ( Figure IIIB in the online-only Data Supplement). In addition, global loss of Bmal1 leads to compensatory thermogenesis in BAT, 41 which might be associated with BP and heart rate. 42 Indeed, selective deletion of Bmal1 in brown adipocytes significantly increased the expression of thermogenic genes such as Ucp1, Cidea, and Elovl3 in PVAT and BAT ( Figure IVA in the online-only Data Supplement). However, the whole-body metabolic indexes in BA-Bmal1-KO mice were comparable to those of wild-type mice when the ambient temperature was set at 22°C or 4°C ( Figure IVB Figure 1D and 1E). This suggests that increasing thermogenesis-related genes in PVAT and BAT of BA-Bmal1-KO mice is likely a compensatory response to impaired thermogenesis in these tissues. To determine whether compensatory thermogenesis in brown adipocytes affects the resting-phase dipping in BP and bradycardia in BA-Bmal1-KO mice, we further analyzed BP, heart rate, and body temperature of the mice housed either in thermoneutral (30°C) or cold (4°C) environments. In a thermoneutral environment, the body temperatures of wild-type and BA-Bmal1-KO mice are comparable during the resting (35.8±0.2°C versus 35.7±0.3°C) and active (36.5±0.2°C versus 36.6±0.1°C) phases ( Figure 1D and 1E). When the temperature was switched from 22°C to 30°C, the BP and heart rate of both wild-type and BA-Bmal1-KO mice significantly dropped. However, compared with wild-type mice, the BP of BA-Bmal1-KO mice was still lower during the resting phase (SBP, 100±4 mm Hg in wild-type versus 87±6 mm Hg in BA-Bmal1-KO), whereas the heart rate of BA-Bmal1-KO mice was higher than that of wild-type mice (heart rate, 338±32 bmp in wild-type versus 365±33 bpm in BA-Bmal1-KO). During the active phase, the BPs of wild-type and BABmal1-KO mice were comparable (SBP, 108±7 mm Hg in wild-type mice and 106±9 mm Hg in BA-Bmal1-KO mice), whereas the heart rate of BA-Bmal1-KO mice was still higher than that of wild-type mice (400±35 bpm in wild-type mice and 429±38 bpm in BA-Bmal1-KO mice). Next, we switched the temperature from 30°C to 4°C. Both BP and heart rate were markedly increased in all mice, accompanied with a decrease in body temperature and locomotor activity ( Figure 1D and 1E) . However, the heart rate of BA-Bmal1-KO mice was lower than that of wild-type mice despite comparable BP between the 2 groups. The steep reduction in body temperature in the BA-Bmal1-KO mice might be caused by a loss of compensatory thermogenesis in brown adipocytes at 4°C. These data are consistent with prior reports that thermogenesis is associated with BP and heart rate in mice. 42 However, the resting-phase dipper BP in the BA-Bmal1-KO mice at 22°C and 30°C is independent of thermogenesis in brown adipocytes.
Brown Adipocyte-Specific Bmal1 Deficiency Does Not Alter the Intrinsic Constriction Ability of Aortic Rings
The constriction levels of aortic rings (PVAT removed) isolated from wild-type and BA-Bmal1-KO mice during the resting phase were comparable in response to stimulation with phenylephrine, serotonin, or Ang II ( Figure  VA in the online-only Data Supplement). In addition, endothelium-dependent and -independent relaxation was similar in aortic rings of wild-type and BA-Bmal1-KO mice (Figure VB in the online-only Data Supplement), indicating that the aortic rings of the BA-Bmal1-KO mice retain an intact ability to contract. Given these findings, it is likely that the hypotensive phenotype in the BA-Bmal1-KO mice is not caused by changes in the aortic intrinsic ability to constrict but rather arises from differences in factors secreted by PVAT in vivo.
Bmal1-Deficient PVAT Is Less Effective in Inducing Vasoconstriction
PVAT produces and releases large amounts of adipokines and other undetermined or less characterized factors that could target ECs and VSMCs and herein contribute to the maintenance of vessel homeostasis. 3, 43 We assessed the vasoactivity of thoracic PVAT extracts from wild-type and BA-Bmal1-KO mice on the wild-type aortic rings from which the PVAT was removed. 15 PVAT extracts from 10, 20, and 30 mg adipose tissue from wild-type mice efficiently constricted recipient thoracic aortic rings harvested from 8-week-old C57BL/6J mice in a dose-dependent manner (Figure 2A and 2B ). In addition, we asked whether PVATinduced constriction of vessel rings was dependent or independent of the endothelium. PVAT (10 mg) extracts still significantly constricted to the same degree the aortic rings devoid of endothelium ( Figure 2C ), indicating that PVAT elicits this response in an endothelium-independent manner. Consistent with the hypotensive phenotype in BA-Bmal1-KO mice, PVAT extracts isolated during the resting phase from BA-Bmal1-KO mice show significantly reduced ability to constrict the wild-type rings ( Figure 2D ) in the same experimental conditions. PVAT isolated from the active phase has 29% higher constriction ability in the wild-type mice ( Figure 2E ), suggesting an intrinsic circadian association of this PVAT function with the ac- 
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tive phase, likely from overall changes in the balance of PVAT-derived contractile factors and PVRFs. Furthermore, this circadian difference is preserved in the BA-Bmal1-KO mice, although there is a remarkable overall reduction in the ability of PVAT from BA-Bmal1-KO mice to constrict the wild-type rings at both time points, indicating that the Bmal1-dependent PVAT contractile dysfunction is preserved throughout the day, despite the BP being normal during the active phase in the knockout mice. This could be the consequence of systemic factors operating during the active phase and overriding the loss of constriction ability arising from the tissue-specific depletion of Bmal1. 44 In that regard, it is noteworthy that sustained systemic infusion of Ang II at pressor levels abolishes the increased hypotensive phenotype but not bradycardia during the resting phase in the BA-Bmal1-KO mice (Figure VIA and VIB in the online-only Data Supplement). In summary, Bmal1 in healthy PVAT contributes to sustain circadian regulation of BP and is required to maintain BP within physiological levels during the homeostatic dipper phenotype associated with the resting phase.
Ang II in PVAT Contributes to Vasoconstriction
PVAT-derived adipokines such as adiponectin, leptin, and chermerin regulate vasoactivity, although our expression data suggest that their contribution may be negligible because they slightly change but in a direction opposing the observed phenotype ( Figure VIIA in the online-only Data Supplement). In addition, the levels of PVAT norepinephrine (a vasoconstrictor 45 ) and PVAT-derived prostacyclin (a vasorelaxant 15 ) in BABmal1-KO mice were indistinguishable from those in wild-type mice ( Figure VIIB and VIIC in the online-only Data Supplement). These data suggest that these PVATderived factors do not likely contribute to the hypotensive phenotype in BA-Bmal1-KO mice. The local RAS in adipose tissues at large is one of the critical elements in the development of hypertension. [46] [47] [48] [49] The majority of the local Agt in the vessel wall is located in PVAT, as opposed to the arterial muscle layers. 49 Although renin mRNA was undetectable in mouse PVAT (data not shown), the Agt mRNA and the Ang II-converting enzyme mRNA in adipose tissues, including PVAT, are expressed in a circadian manner ( Figure 3A ), higher during the resting phase and lower during the active phase. The Agt circadian variation is lost in PVAT and BAT of the BA-Bmal1-KO mice, showing consistent lower levels ( Figure 3A ) reflected in the reduced total Ang II in the Bmal1-deficient PVAT extracts ( Figure 3D ). Plasma Agt and Ang II levels also showed a circadian variation ( Figure 3B and 3C ), although they were not affected in the BA-Bmal1-KO mice. Subcutaneous white adipose tissue (WAT) is recognized as a beige adipose tissue containing some Ucp1-positive adipocytes 50 and hence 
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potentially affected by our knockout strategy. However, in this context, subcutaneous WAT was more similar to gonadal WAT in that the Agt mRNA circadian variation is comparable between wild-type and BA-Bmal1-KO mice housed at 22°C ( Figure 3A) . Although the Agt mRNA in BAT of BA-Bmal1-KO mice was reduced, the plasma concentrations of Agt and Ang II were comparable between wild-type and BA-Bmal1-KO mice ( Figure 3B and 3C), indicating that brown adipocyte-derived Agt has negligible contribution to the circulating Agt and Ang II pools. Thus, the local RAS-derived components in PVAT might contribute to circadian rhythmicity of BP in a Bmal1-dependent fashion. We investigated whether RAS in PVAT is involved in vessel ring constriction induced by PVAT extracts. The recipient vessel rings that were pretreated in a dose-dependent manner with type 1 Ang II receptor blockers (valsartan or losartan, 10 −8 to 10 −6 mol/L) showed a significantly lower response to PVAT extracts from wild-type mice ( Figure 3E and 3F) , further supporting that local PVAT-derived Ang II may be associated with vessel constriction induced by PVAT extracts. These findings are consistent with the observed hypotensive phenotype during the resting phase and the reduced vasoconstriction ability of PVAT from the BA-Bmal1-KO mice, suggesting a direct relationship between Bmal1 and Agt/Ang II expression in the peripheral clock in this tissue.
Deletion of Agt in Brown Adipocytes Leads to Hypotension During the Resting Phase in Mice
To further establish that RAS in PVAT contributes to circadian BP regulation, we generated BA-Agt-KO mice. Agt protein was present in all types of adipose tissues ( Figure 4A ) from the wild-type mice but was undetectable in PVAT and BAT from BA-Agt-KO mice ( Figure 4B ). The PVAT Ang II levels in BA-Agt-KO mice were reduced >90% compared with wild-type PVAT ( Figure 4C) . Consistently, the PVAT extracts from BAAgt-KO mice showed a significantly reduced ability to constrict wild-type vessel rings ( Figure 4D ), comparable to the BA-Bmal1-KO mice. The daytime resting-phase BP at 22°C is significantly reduced in the BA-Agt-KO mice compared with the wild-type mice, whereas the nighttime active-phase BP is preserved and comparable to that of the wild-type mice ( Figure 4E 
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the BA-Bmal1-KO phenotype of exacerbated restingphase dipping in BP. As in the BA-Bmal1-KO mice, the heart rate in the BA-Agt-KO mice is lower during both daytime and nighttime with preserved and comparable locomotor activities ( Figure 4E and 4F) . The response to IP injection of isoproterenol during the resting phase parallels that of the BA-Bmal1-KO mice ( Figure VIII in the online-only Data Supplement). In addition, the heart rate in the mice was changed by switching the environmental temperature from 22°C to 30°C or from 30°C to 4°C (Figure 4E and 4F) . At 30°C, the heart rates of the BA-Agt-KO mice were reduced to the same level as those of wild-type mice. However, the resting-phase BP was still lower in BA-Agt-KO mice than in wild-type mice. On the other hand, 4°C environmental stimulus significantly elevated both the BP and heart rate in BAAgt-KO mice to levels comparable to those of wild-type mice. The body temperature and locomotor activity are comparable between wild-type and BA-Agt-KO mice in all experimental conditions ( Figure 4E and 4F). Combined, these results suggest that bradycardia of BA-Agt-KO mice in the 22°C environment is unlikely to drive the superdipper phenotype in BP. In addition, despite the lower heart rate, the cardiac function parameters of BA-Agt-KO mice are similar to those of wild-type mice ( Figure IXA in the online-only Data Supplement). Furthermore, the aortic rings from BA-Agt-KO mice isolated during the resting phase (10 am) and devoid of PVAT show intrinsic constriction properties comparable to those of wild-type mice when vasoactivity is induced by phenylepherine, serotonin, and Ang II and are indistinguishable from wild-type rings in endotheliumdependent and -independent relaxation assays ( Figure  IXB and IXC in the online-only Data Supplement). This suggests that the hypotensive phenotype during the resting phase in the BA-Agt-KO mice is caused by the Agt deficiency in PVAT. In addition, the fact that BAAgt-KO recapitulates the BA-Bmal1-KO phenotypes is consistent with a Bmal1-Agt-Ang II axis accounting for the hypotensive phenotype in the resting phase. 
Agt Is a Novel Transcriptional Target of Bmal1 in PVAT
Bmal1 is expressed in PVAT in a circadian rhythmic manner. Agt expression in PVAT appears to follow a circadian rhythm as well, although it is right-shifted compared with Bmal1 ( Figure 5A ), suggesting delayed expression and opening the possibility that Bmal1 may function as a transcriptional regulator for Agt. We found a putative Bmal1 binding site (CACATG box) located between −808 and −814 bp upstream of the Agt transcription start site. In a luciferase reporter assay ( Figure 5B ), a 1543-bp region from the Agt promoter containing that putative Bmal1 E-box displayed a 4-fold increase in reporter activity relative to the control vector in response to overexpression of mouse Bmal1 in HEK293 cells, whereas mutation of the E-box abolished this response. Chromatin immunoprecipitation analysis confirmed Bmal1 protein binding to the Agt promoter region harboring the proximal CACATG motif located between −808 and −814 bp upstream of the transcription start site ( Figure 5C ). A negative control, isotypic IgG antibody, does not pull down the promoter, demonstrating that this is a functional Bmal1 binding site in the Agt promoter. Furthermore, lentivirus-mediated overexpression of Bmal1 significantly upregulated Agt mRNA (Figure 5D ) and protein ( Figure 5E ) levels in brown adipocytes. These data indicate that Bmal1 binds to the Agt promoter and functionally upregulates Agt expression in brown adipocytes and are consistent with the reduced Agt expression we observed in our BA-Bmal1-KO PVAT mice, thus defining Agt as a novel target of Bmal1 of physiological relevance for circadian regulation of BP in PVAT.
DISCUSSION
Adipose tissues in the body are essential for physiological homeostasis. Obesity is positively associated with hypertension and related cardiovascular diseases. Mice lacking all adipose tissues display hypertension and insulin resistance. 51 Unlike WATs in visceral and subcutaneous regions, the PVAT, which surrounds large arteries such as the aorta, is a BAT-like adipose tissue functionally different from WAT. 3, 15 However, the nature and extent of functional relationships between PVAT and the other layers of the blood vessels are still largely unknown. PVAT is actively involved in regulation of BP by controlled release of contractile and anticontractile fac- 
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tors, among a plethora of paracrine mediators ensuring vessel homeostasis. 3, 52, 53 However, the specific role of PVAT in regulation of BP is unclear. We showed that selective lack of PVAT enhanced atherosclerosis, 15 and those mice were hypotensive during the resting phase. 19 The mechanisms for central circadian systems control of BP rhythmicity have been well reviewed. 54 However, the peripheral circadian system in blood vessels contributes to BP circadian rhythmicity as well. 55 Bmal1 is expressed in both ECs and VSMCs. Bmal1 in the vasculature is transcriptionally controlled by PPARγ. Knockout of PPARγ in ECs or VSMCs significantly reduced circadian variation in BP and heart rate. 31 Bmal1 in VSMCs regulates Rho-kinase 2 transcription, whereas deletion of Bmal1 abolished myosin phosphorylation, ROCK2 activation, and agonist-induced vasoconstriction. Mice deficient for Bmal1 in ECs or VSMCs had compromised BP circadian rhythmicity and decreased SBP during the nighttime active phase and reduced heart rates throughout the day. 30, 32 Ang II regulates circadian clocks in the SCN 56 and VSMCs. 57 Here, we demonstrate that components of the peripheral clock show circadian regulation in PVAT. Furthermore, the Bmal1 protein in PVAT of mice is acutely repressed by systemic Ang II infusion. Consistently, the circadian rhythmicity of BP is temporarily abolished with recovery at day 4 of Ang II infusion, when Bmal1 levels are restored, thus linking Bmal1 expression in PVAT to the circadian regulation of BP.
Selective deletion of Bmal1 in brown adipocytes in mice does not affect the intrinsic ability of the ECs and VSMCs to respond to contractile stimuli. Unlike Bmal1 deficiency in ECs or VSMCs, 30, 32 the BP in BA-Bmal1-KO mice is reduced only during the resting phase, and impaired local RAS, evidenced by strikingly lower levels of Ang II in PVAT, can account for that phenotype in this novel mouse model. During the active phase, when BP and heart rate are simultaneously increased together with the SCN-controlled locomotor activity, BP is normal in BA-Bmal1-KO mice. Although PVAT extracts collected from BA-Bmal1-KO and wild-type mice during the night active phase enhanced vasoconstriction differently, it is possible that during the active phase, altered local PVAT-derived vasoconstrictors such as Ang II in the BA-Bmal1-KO mice may be overcome by sympathetic nerve-mediated elevation of BP observed in vivo, 58 thus allowing the BABmal1-KO (and BA-Agt-KO) mice to present normal BP during the active phase.
Systemic deletion of Agt in adipocytes, including white adipocytes, leads to systemic reduction in Ang II and hypotension, 59 although our data uncovered that brown adipocyte-selective Agt deficiency is hypotensive only during the resting phase associated with reduced local Ang II production, recapitulating the BA-Bmal1-KO phenotype, without affecting systemic levels of Ang II. Furthermore, we determined that Agt, which depicts circadian expression in PVAT, is a direct transcriptional target of Bmal1 in PVAT through a functional Bmal1 E-box at −808 to −814 in the cognate Agt promoter. These data are consistent with the loss of PVAT-derived local Ang II in both BA-Bmal1-KO and BAAgt-KO mice associated with reduced vascular tone in the resting phase, suggesting that local Ang II is one of vasoconstrictors contributing to this PVAT phenotype in a paracrine fashion.
Diurnal variations in BP are essential to cardiovascular homeostasis. Variations in the physiological drop (dipping) in BP during the resting phase are known risk factors for cardiovascular events. 60 These phenotypes are referred to as nondipper (failure to downregulate BP in the resting phase) or superdipper (exacerbated hypotension during the resting phase), and both are known to be strongly related to individual risk of cardiovascular morbidity and mortality. 39 The coordinated effects between the central clock and tissue-specific peripheral clocks may account for these phenotypes, although their cross-talk is not clearly defined so far. Thus, upregulation of the RAS in rats with severe hypertension results in an inverted BP profile. 61 It was proposed that circulating Ang II mediates this phenomenon. 62, 63 Central Bmal1 involvement in that model is evidenced by loss of its rhythmic expression. 64 In adipocytes of healthy PVAT, during the resting phase, we uncovered a circadian regulated axis defined by Bmal1 transcriptionally upregulating Agt expression to ensure physiological levels of Ang II in PVAT to sustain vascular tone during the normal dip in BP associated with the resting phase. Our brown adipocyte-specific Bmal1 and Agt knockout mice present a dipping profile consistent with a superdipper phenotype during the resting phase in vivo. Superdippers are at risk for silent myocardial ischemia and nonfatal ischemic stroke, whereas hypertensive patients with superdipper BP are likely to have silent cerebral infarct and to be at high risk for future stroke. 65 Whether our novel mouse models reported here will recapitulate such cardiovascular risks and adverse outcomes remains to be determined. In addition, it is possible that a phase shift or change in amplitude in this local PVAT homeostatic control of BP during the resting phase may be associated with adverse cardiovascular outcomes in shift workers and individuals with jet lag. 66 Furthermore, the PVAT peripheral clock may be altered in the context of obesity, which is known to cause both PVAT dysfunction 67, 68 and overall disruption of systemic circadian cycles. 69 Future studies should also address the molecular aspects of cross-communication between known drivers of systemic oscillation of BP and the synchronization of the local PVAT peripheral clock. For instance, it is likely that systemic Ang II might be tied in a regulatory loop with PVAT controlling local Bmal1 expression, phosphorylation, subcellular local-
